resources

Resource Center

2009 Forum video excerpts

Selected short (<2 mins) video clips from 2009 Abu Dhabi-GCC Health and Development Investment Forum

Opening session – Day 1

Opening Welcome (Arabic and English) – Samih Darwazah (Founder and Chairman of Hikma Pharmaceuticals  PLC) – opening comments: Click here to view

Opening comments -  HE Dr Hamad Al Ghaferi (Director General of the National Rehabilitation Center – Emirate of Abu Dhabi): Click here to view

Panel Discussions – Days 1 and 2

Investing in meeting the health challenges of the GCC – The case for focusing on reducing real disease burden – comment by Professor Philippe Chossegros: Click here to view

Special Session: Influenza Pandemic 2009: The legacy for health systems strengthening in the Middle East – comments by Louis-Charles Viossat (former French Ambassador in charge of the fight against AIDS and Communicable Diseases); Jane Homan (IoGenetics); Donald Gerson (PnuVax): Click here to view

Healthcare Services Masterclass – comments by Stephen Walston (University of Oklahoma); Abdul Karim Al Fahim (Mafraq Hospital, Abu Dhabi); Oliver Tattan (The Regulated Industry Group); Tom Kass (EFG International); Mohan Chellapa (Johns Hopkins Medicine International): Click here to view

The role of industry, investors, private equity and venture capital in healthcare sector development - comments by Imad Ghandour (Gulf Capital and GVCA); Yahya Jalil (The National Investor); Wassim Mourtada (Envision); Khaled  Jaouni (Ithmar Capital): Click here to view

Investing in healthcare R&D – comments by Christopher Earl (BIO Ventures for Global Health); Andreas Wicki (HBM BioVentures AG); Mark Carthy (Orion Partners); Naveed Siddiqi (Nomura Phase4 Ventures): Click here to view

Building healthcare infrastructure and services – comments by Mohammed Mutabagani (Chairman of The National Health Committee Saudi Council of Chambers of Commerce); Ayesha Abdullah (Dubai Health Care City); Ali Abdulkareem Alobaidli (Clinical Affairs Director, SEHA- Abu Dhabi Health Services Company); Fadi El-Jardali (American University of Beirut): Click here to view

Excellence in health system development in the UAE and GCC: Lessons learnt and the way forward - comments by Alexander Vogler (Daman – Abu Dhabi); Joseph Boulos (NAS Administration Services); Mohan Chellappa (Johns Hopkins Medicine International); Abdulaziz Soudani (Biopharm Tunisia): Click here to view

Financing the healthcare and life sciences sectors: implications of the global economic crisis – comments by Marcus Sasse (UBS, KSA); Tom Healy (Abu Dhabi Securities Exchange); Simon Turton (Warburg Pincus); Harald Stock (Grünenthal Group): Click here to view

Is R&D meeting global disease challenges? – comments by Christopher Earl (BIO Ventures for Global Health); Chris Hentschel (Medicines for Malaria Ventures); Jean-Pierre Paccaud (Drugs for Neglected Diseases Initiative); Robert Sebbag (Sanofi Aventis); Herman van Cauteren (Neglected Diseases Foundation); Dan Stinchcomb (Inviragen): Click here to view

Resources

WHO Venice Draft Concluding Statement on Maximizing Positive Synergies between health systems and Global Health Initiatives – click here to download the document

Links

Strengthening research capacity in Africa – African Institutions Initiative